| Authors: |
Wang Y; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncostat U1018, the Institut National de la Santé et de la Recherche Médicale (Inserm), Labeled Ligue Contre le Cancer, Paris Saclay University, Villejuif, France., Drubay D; Office of Biostatistics and Epidemiology Department, Gustave Roussy, Paris Saclay University, Villejuif, France; Oncostat U1018, the Institut National de la Santé et de la Recherche Médicale (Inserm), Labeled Ligue Contre le Cancer, Paris Saclay University, Villejuif, France; National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France., Jonas SF; Office of Biostatistics and Epidemiology Department, Gustave Roussy, Paris Saclay University, Villejuif, France; Oncostat U1018, the Institut National de la Santé et de la Recherche Médicale (Inserm), Labeled Ligue Contre le Cancer, Paris Saclay University, Villejuif, France., Dixon-Douglas J; The Institut National de la Santé et de la Recherche Médicale, Unit 981 Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France; Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Acs B; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden., Adams S; Medical Oncology, New York University Langone Laura and Isaac Perlmutter Cancer Center, New York, USA., André F; Office of Biostatistics and Epidemiology Department, Gustave Roussy, Paris Saclay University, Villejuif, France; Oncostat U1018, the Institut National de la Santé et de la Recherche Médicale (Inserm), Labeled Ligue Contre le Cancer, Paris Saclay University, Villejuif, France., Badve S; Department of Pathology and Lab Medicine, Emory University, Atlanta, USA., Bataillon G; Pathology Department, Toulouse University, Oncopole Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Carter JM; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada., Chia S; British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada., Cockenpot V; Department of Pathology, Léon Bérard Cancer Center, Lyon, France., Colleoni MA; Division of Medical Senology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy., Criscitiello C; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Curigliano G; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Dackus GMHE; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Demaria S; Radiation Oncology and Pathology, Weill Cornell Medicine, New York, USA., Denkert C; Institute of Pathology, Philipps-University Marburg and University Hospital Marburg, Marburg, Germany., van Deurzen CHM; Department of Pathology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Oncology 2, Istituto Oncologico Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy., Giardiello D; Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy., Goetz MP; Department of Oncology, Mayo Clinic, Rochester, USA., Gray RJ; Eastern Cooperative Oncology Group-American College of Radiology Imaging Network, Biostatistics Center, Dana Farber Cancer Institute, Boston, USA., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Ter Hoeve ND; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Koop EA; Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, the Netherlands., de Jong VMT; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Joensuu H; Department of Oncology, Helsinki University Hospital and Helsinki University, Helsinki, Finland., Jules-Clément G; Bioinformatics Core Facility, Gustave Roussy, Université Paris Saclay, The Institut National de la Santé et de la Recherche Médicale, US23, Centre National de la Recherche Scientifique Unité Mixte de Service 3655, Villejuif, France., Kammler R; International Breast Cancer Study Group, a division of European Thoracic Oncology Platform International Breast Cancer Study Group Partners Foundation, Bern, Switzerland., Kellokumpu-Lehtinen PL; Department of Oncology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Kok M; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Lacroix-Triki M; Department of Anatomical Pathology, Gustave Roussy, Villejuif, France., Lambertini M; Department of Medical Oncology, Academic Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Metropolitana, Genova; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genova, Italy., Lee HJ; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Lemonnier J; Unicancer Group, Paris, France., Leon-Ferre RA; Department of Oncology, Mayo Clinic, Rochester, USA., Leung S; British Columbia Cancer and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Linderholm B; Sahlgrenska University Hospital, and Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden., Loibl S; German Breast Group Forschungs GmbH and University Hospital Frankfurt, Forschungs, Germany., Martens JWM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Nielsen TO; British Columbia Cancer and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Opdam M; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Pharoah P; Department of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, USA., Penault-Llorca F; Department of Biopathology, Centre Jean Perrin, Université Clermont Auvergne, the Institut National de la Santé et de la Recherche Médicale, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France., Piccart M; Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Pustzai L; Yale Cancer Center, Yale School of Medicine, New Haven, USA., Riaz N; British Columbia Cancer and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; Institute of Clinical Sciences, Department of Surgery, University of Gothenburg, Sweden., Vincent-Salomon A; Department of Pathology, Institut Curie, Paris, France., Sparano J; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USA., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Suman VJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, USA., Timmermans AM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., Viale G; Department of Pathology & Laboratory medicine, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy., Wolff AC; Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre, Lutherville, USA., Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yoshida M; Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan., Salgado R; Department of Anatomical Pathology, Ziekenhuis aan de Stroom-Hospitals, Antwerp, Belgium; Department of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Linn SC; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Schmidt MK; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: mk.schmidt@nki.nl., Loi S; Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Department of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Michiels S; Office of Biostatistics and Epidemiology Department, Gustave Roussy, Paris Saclay University, Villejuif, France; Oncostat U1018, the Institut National de la Santé et de la Recherche Médicale (Inserm), Labeled Ligue Contre le Cancer, Paris Saclay University, Villejuif, France; National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France. |
